The expression of multiple connexin (Cx) types in the epidermis, their differential expression during wound closure and the association of skin pathology with specific Cx gene mutations, are indicative of important functions for Cxs in the skin. In this review, we focus on the role of Cx proteins in the epidermis and during wound healing and discuss mutations in Cx genes which cause skin disease. This article is part of a Special Issue entitled: The Communicating junctions, composition, structure and characteristics.
to form a homotypic GJ channel, consisting of the same two hemichannel types, or a heterotypic GJ channel, comprising different hemichannel types. 21 Cx types are found in humans and 20 in mice with most tissue types expressing one or more Cx proteins. A range of diseases are attributable to Cx gene mutations including syndromic disease (in which multiple tissue types are affected), skin disease, non-syndromic hearing loss (NSHL) (hearing loss only), cataracts and neurological disorders. Here, we focus on what is known about the role of Cxs in epidermal barrier homeostasis, wound healing and the association of Cx gene mutations with skin disease.
Connexin localisation in the epidermis
The epidermis of skin is made up of the basal (deepest) layer (BL), spinous layer (SL), granular layer (GL) and the uppermost stratum corneum (SC). Keratinocyte (skin) cells undergo a differentiation program characterised by the expression of different markers as they migrate upwards from the mitotically active BL to ultimately form the SC composed of dead anucleated corneocytes.
Cxs have an important role in epidermal physiology, indicated by the expression of multiple Cx types in the skin and epidermal appendages, and the link between Cx gene mutations and disease involving the skin. GJs are expressed throughout the epidermis, with the exception of the SC [3, 4] , and Cxs are expressed in each epidermal layer with some overlap in expression of the different Cx types, indicating a purpose for Cxs in coordinating keratinocyte differentiation [5, 6] .
Cx26, Cx30, Cx30.3, Cx31.1, Cx37 and Cx43 are expressed in both human [7, 8] and rodent epidermis [4, 9, 10] . In human interfollicular skin, Cx30, Cx30.3, Cx31 and Cx45 are expressed in the GL and low levels of Cx26 in the BL and GL of palmoplantar skin [6, 8, 11] . Cx43 is mainly expressed in the suprabasal layers, the highest expression of which is in the GL [8, 12] . In adult rodents, Cx43 is predominantly expressed in the BL and Cx26, Cx30, Cx31 and Cx31.1 in the suprabasal layers [4, [13] [14] [15] .
Differential connexin localisation in the skin after wounding
Wound healing involves a complex sequence of events including inflammation, tissue formation and remodelling. Keratinocytes at the wound margins proliferate and migrate into the wound where differentiation occurs to repair the breached epidermal barrier (reviewed in [16] ). Expression patterns of Cx proteins during wound closure in rodent skin and in ex vivo wound healing models have shown differential Cx expression in response to injury, indicative of key functions for Cxs in wound remodelling [14, 17, 18] .
The differential expression of certain Cx types during keratinocyte differentiation and the wound healing process could permit critical alterations in GJIC which allow these physiological processes to occur. However, increasing numbers of studies are revealing Cx interacting partners and cellular functions for Cxs which are irrespective of their GJ function (reviewed in [19] [20] [21] ). For example, Cx43 has been found to interact with structural, signalling and membrane proteins including zona occludens proteins, members of which are constituents of tight junctions and adherens junctions, and catenins, which are components of adherens junctions (reviewed in [20] ). Thus, potentially Cxs may mediate effects on epidermal biology by non-GJ mechanisms via Cx partner proteins.
The majority of studies investigating the differential expression of Cxs in wound healing have focused on Cx26, Cx30 and Cx43 (Sections 3.1 and 3.2). Cx31.1 expression initially decreased at the wound site in rodents [14, 17] . Levels returned to normal after 6 days in rats [17] . However an increase in Cx31.1 expression was noted after 7 days in mice before returning to normal at 12 days, indicative of a role for Cx31.1 in terminal differentiation [14] . Cx31 was downregulated in the suprabasal layer after injury in mice, with levels increasing after day 3 [15] . However expression in the BL increased up to day 3 before returning to low levels characteristic of uninjured skin [15] .
Connexin 26 and Connexin 30
Initially, the expression of Cxs types studied was low at the wound site and proximal areas after injury, followed by an upregulation of some Cx types at different time points [14, 17, 18] . Cx26 and Cx30 were upregulated in response to wounding, although the exact location at which this occurs differs between studies, and between species examined [14, 17, 18] . In rats, Cx26 expression increased behind, but not at, the wound edge between 6 h to 6 days after gouging [17] . A similar expression pattern for Cx26 and Cx30 was observed in human ex vivo wound healing models [18] . Tape-stripping of human skin led to increased Cx26 expression throughout the epidermis [6] . In mice, Cx26 and Cx30 were upregulated behind the edge of, and in, the leading edge of the wound 1-4 days after injury [14] .
The reason for Cx26 and Cx30 upregulation during the initial wound healing response is unclear. Mutations in both GJB2 and GJB6, which encode Cx26 and Cx30 respectively, are linked to syndromic disorders characterised by epidermal thickening (Sections 5.1 and 5.2). GJB2 has also been identified as a psoriasis susceptibility locus in the Chinese population [22] . The persistent expression of Cx26 in murine epidermis resulted in hyperproliferation and hindered wound healing [23] , and in chronic leg ulcers Cx26 and Cx30 were present at, and in close proximity to, the wound margins [18] . Cx26 was upregulated in human hyperproliferative psoriatic lesions compared to non-lesional skin [6, 24] , however Cx26 was also found to be highly expressed in normal buccal and vaginal epithelium, suggesting that Cx26 has a role in normal keratinocyte differentiation [6] .
Collectively, these studies indicate that Cx26 and Cx30 may control wound healing by regulating keratinocyte proliferation, differentiation and/or migration, but that their abnormal expression in the epidermis can be associated with hyperproliferative disease and may be detrimental to wound closure [14, 17, 18] .
Perhaps surprisingly, Cx26 expression is not essential in skin, possibly because of compensatory mechanisms by other Cxs in the epidermis. Patients homozygous for some of the most frequent NSHL GJB2 mutations such as c.35delG and c.235delC, which cannot form functional GJs [25, 26] , have NSHL but not skin disease. Interestingly, an increased epidermal thickness, but not skin pathology, is associated with being a carrier of c.35delG or of another NSHL Cx26 mutant, p.R143W, and it has been suggested that they may confer a heterozygote advantage to carriers [27] [28] [29] [30] (reviewed in [31] ).
Connexin 43
After wounding, Cx43 expression decreased at the wound site and surrounding areas in the epidermis of rats, mice and humans [14, 17, 32] and Cx43 remained low throughout the entire wound healing process in humans [18] . However, Cx43 was expressed at the margins of chronic non-healing wounds in humans [18] and in the wound edges of diabetic mice, which are slow to heal [33] . This demonstrates that Cx43 downregulation appears to be necessary for efficient wound re-epithelialisation [18, 33] .
A reduction in Cx43 hemichannel and/or GJ function by Cx43 knockdown or Cx43 mimetic peptides, has been shown to increase wound healing time and reduce inflammation, which may warrant their use in the future as therapeutics [15, [34] [35] [36] [37] [38] . Transient Cx43 knockdown in areas of epidermal wounding or burn lesions in mice led to increased keratinocyte proliferation, increased keratinocyte and fibroblast migration, decreased inflammation, swifter wound closure and reduced scarring [34] [35] [36] .
The mimetic peptides Gap26 and Gap26M, which interact with different Cx types, and Gap27, which targets Cx43, were found to increase fibroblast and keratinocyte migration in vitro [37] . Gap27 increased keratinocyte and fibroblast migration into the wound of 3D mouse organotypic cultures [39] . It also increased the migration and proliferation of normal human keratinocytes and fibroblasts and accelerated wound closure in 3D human organotypic cultures and ex vivo wound healing models [38] . However, keratinocytes from diabetic patients showed decreased sensitivity to Gap27 compared to control, illustrating a potentially variable response of cells of different origin to the peptides [38] .
Mice expressing the truncating Cx43 mutant p.K258X displayed aberrant barrier formation [40] and fibroblasts isolated from patients with Oculodentodigital dysplasia (ODDD) Cx43 mutants, which display reduced GJIC, showed impaired migration and proliferation [41] . These investigations indicate that transient inhibition of Cx43 expression or GJ function promotes wound healing, but that chronic loss of Cx43 function could have a detrimental effect on epidermal barrier homeostasis and wound healing.
Mechanism of connexin mutations in disease
How Cx disease mutants cause pathogenesis in vivo is unclear for the majority of mutants, although functional investigations have given insights into potential disease-associated mechanisms ( Fig. 1) .
A Cx mutant could be unable to form functional GJ channels, thus ablating its normal physiological role in a tissue it is expressed in. For example, insertion/deletion NSHL Cx26 mutants such as c.35delG result in a truncated Cx26 protein that cannot form functional GJs [25] . Loss of normal Cx26 function may impair K + recycling in the inner ear [42, 43] and cause cell death in the cochlea, leading to deafness [44, 45] . However, the loss of functional Cx26 GJs only in the epidermis is not the sole cause of skin disease, as patients homozygous for loss of function deafness mutations do not exhibit skin pathology. A mutant may mistraffic, and instead of reaching the cell surface membrane accumulates in organelles or leads to endoplasmic reticulum (ER) stress. For example, X-linked Charcot-Marie-Tooth (CMTX) disease Cx32 mutants accumulate in the ER and Golgi apparatus [46] [47] [48] [49] and ER stress is associated with the overexpression of erythrokeratoderma variabilis (EKV) Cx31 mutants [50] .
The exertion of a dominant negative effect by a Cx mutant on the functioning of wild-type Cx protein and/or on other Cx types could lead to disease. Specific Cx types can form heteromeric hemichannels and heterotypic GJs with other selected Cx types, such as Cx31 with Cx26, Cx30 and Cx32 [11, 51] thus a Cx mutant may also affect other Cxs it interacts with. An example of this is the palmoplantar keratoderma (PPK) and deafness mutant p.del42E, which was shown to have a dominant negative effect on Cx26, Cx37 and Cx43 [52] . As Cxs may interact with partner proteins (reviewed in [20] ), it is possible that a mutant could also have a dominant negative effect on a Cx binding protein.
A Cx mutant may be incorporated into hemichannels, but at the plasma membrane they cause deregulated exchange of molecules with the extracellular environment. In vitro studies with certain syndromic Cx26 and Cx30 mutants have indicated that they form 'leaky' hemichannels at the cell surface [53] [54] [55] [56] . If aberrant hemichannels were expressed in the epidermis, they could lead to deregulated release of molecules such as ATP, leading to skin disease pathology [53] .
Connexins and skin disease
The important physiological role of Cxs in tissue is demonstrated by the range of different Cx types often expressed in a single tissue, and the link between Cx gene mutations and disease. The first report of a link between mutations in a Cx gene and disease was in 1993 when different mutations in GJB1 (Cx32) were identified in patients with CMTX disease [57] . Mutations in GJB2 (Cx26), GJB3 (Cx31), GJB4 (Cx30.3) and GJB6 (Cx30) are linked to syndromic disease, skin disease only and NSHL, and in GJA1 (Cx43) to ODDD with or without PPK ( Table 1) .
Syndromic skin disease caused by Connexin 26 mutations
Specific dominant missense and deletion mutations in GJB2 (Cx26) the majority of which affect amino acids in the N-terminus (NT) or the first extracellular loop (EL1), are associated with syndromic skin disease (Table 2) . A generalised characteristic of syndromic skin diseases linked to Cx26 mutations is PPK and deafness. Cx26 mutations are implicated in causing PPK with deafness only, the 'classical' form of Vohwinkel syndrome (VS), keratitis-ichthyosis-deafness (KID) syndrome, Bart-Pumphrey syndrome (BPS) and hystrix-like ichthyosisdeafness (HID) syndrome. Certain Cx26 mutations cause different diseases indicating clinical heterogeneity, for example p.D50N is linked to KID syndrome [58] [59] [60] [61] [62] and HID syndrome [63] . Cx26 mutations are also associated with NSHL [64] , a full list of dominant and recessive mutations can be found on The Connexin-deafness homepage [65] .
BPS is characterised by knuckle pads on the metacarpophalangeal and interphalangeal joints of the hand, leukonychia (whitening of the nails) and sensorineural hearing loss [66] . Two Cx26 mutations, p.N54K [67] and p.G59S [68] , have been found to be associated with BPS. Immunohistochemical staining on lesional skin from a BPS patient with p.N54K showed that the trafficking of Cx26, Cx30 and Cx43 did not appear to be disrupted but that Cx30 was upregulated, possibly to functionally compensate for expression of p.N54K [67] .
KID syndrome patients present with mild to severe sensorineural loss, keratitis which can lead to blindness, loss of eyelashes and eyebrows and increased susceptibility to infections and squamous cell carcinoma. Hyperkeratosis, PPK and the development of localised red/brown hyperkeratotic lesions can occur in patients [69, 70] (Fig. 2) . The mutation p.G45E was found to be associated with severe disease, causing fatality in the first year of life [61, 71] . HID syndrome shows clinical overlap with KID syndrome, however HID syndrome is characterised by the presence of 'spiky' hyperkeratosis with a cobblestone-like presentation over the body [63] . KID syndrome mutations are found in the NT or EL1 of Cx26. The NT and NT/EL1 boundaries of Cxs have been hypothesised to have a role in voltage sensing in GJs [72] . X-ray crystallography of Cx26 has shown that the NT and NT/EL1 boundaries are located in regions which may be important in determining size restriction and pore selectivity [73] , thus mutations in these regions could influence GJ properties and thus cause disease.
Characteristics of the 'classical' form of VS, or VS linked to Cx26 mutations, include sensorineural deafness, constriction of the digits (pseudoainhum) which may lead to autoamputation and starfishlike keratosis [74, 75] . Hair abnormalities are not present. Both 'classical' VS and a distinct disorder, VS with ichthyosis, are characterised by pseudoainhum. VS with ichthyosis differs from 'classical' VS in that the disorder is linked to one base pair insertion mutations in the loricrin gene, LOR, and thus is considered a loricrin keratoderma (OMIM 604117). VS with ichthyosis patients have normal hearing and generalised ichthyosis [76] [77] [78] .
It is unclear as to why Cx26 mutations associated with syndromic disease are dominant, but indicates that the mutant protein acquires an aberrant function in specific cell types, leading to disease. Functional investigations have indicated that certain syndromic Cx26 mutants have a dominant negative effect on wild-type Cx26 or on other Cx types, do not form functional gap junctions and/or form 'leaky' hemichannels at the cell surface membrane [52, [54] [55] [56] 79, 80] (Table 3) . Specific PPK and deafness mutants and VS mutants appear to exert a dominant negative effect, indicated by the retention of wild-type Cx26 or other Cx types in the cytoplasm of cells, or by their inhibition of GJIC between GJs [52, [79] [80] [81] [82] . For example, in transgenic mice p.D66H had a dominant negative effect on wild-type Cx26 and Cx30, indicated by their retention in the cytoplasm [79] . When coexpressed with wild-type Cx26 and Cx30 in Xenopus oocytes [52] or cell lines [83] , p.D66H reduced intercellular coupling, indicating a dominant negative effect.
Hemichannel activity at the cell surface membrane is believed to be greatly reduced or absent due to their closure at 1-2 mM of extracellular Ca 2+ or higher [84] [85] [86] [87] and thus incubation in high Ca
2+
should close hemichannels present at the cell surface membrane. The KID syndrome mutants p.G12R, p.N14K, p.A40V, p.G45E and p.D50N have been hypothesised to form leaky hemichannels, indicated by large outward membrane currents from Xenopus oocytes expressing the mutants, which could be prevented by raising the extracellular Ca 2+ [55, 56] . Increased propidium iodide loading of HEK-293T cells transfected with p.G45E could be prevented by raising the extracellular Ca 2+ levels, leading to the conclusion that this mutant led to aberrant hemichannel formation [54] . However, results of expression studies with KID Cx26 mutants in Xenopus oocytes, indicating that hemichannels are present, are not always recapitulated in transfected cells. This might be due to differences in the processing of the mutants in different model systems. In addition, there was no evidence of the p.S17F mutant forming hemichannels even in Xenopus oocytes, indicating a different mechanism of pathogenesis for this mutant [56] . High Ca 2+ rescued the cell death phenotype caused by overexpression of the mutant p.D50N in Xenopus oocytes [56] but not in transfected HEK-293T cells in vitro [88] . Decreased cell viability was observed for HeLa cells transfected with p.N14K, however the mutant had a cytoplasmic localisation and appeared to be retained in the ER, indicating that defective protein trafficking could lead to disease [89] .
Hidrotic ectodermal dysplasia (HED) caused by Connexin 30 mutations
Specific dominant missense mutations in GJB6 (Cx30) are associated with hidrotic ectodermal dysplasia (HED), also known as Clouston syndrome. These include p.G11R and p.A88V [90] , which have also been discovered in cases of atypical pachyonychia congenita [91] , and p.V37E [92] . A patient with KID syndrome with atrichia (absence of hair) was found to harbour the Cx30 mutation p.V37E, possibly because of a similar functional effect of this mutant compared to KID syndrome Cx26 mutants [93] . There is some overlap in the expression of Cx26 and Cx30 in palm skin [8] and the cochlea [94] and the two have been shown to interact in vitro [11] . This, and the phenotypic similarities between diseases linked to Cx26 and Cx30 mutants, indicate that the two proteins have similar functional roles in vivo.
HED patients display nail hypoplasia, PPK, skin hyperpigmentation and hair defects which can cause total alopecia. Overexpression of p.G11R and p.A88V in Xenopus oocytes showed that although GJs were formed, their conductance properties were altered [53] . Large outward membrane currents were discovered and oocyte death occurred, which could be rescued by raising the extracellular Ca 2+ levels, indicating the presence of aberrant hemichannels [53] .
Erythrokeratoderma variabilis (EKV) caused by Connexin 30.3 and Connexin 31 mutations
The main feature of erythrokeratoderma is the presence of localised demarcated hyperkeratotic (thickened) skin lesions in patients. The two major erythrokeratoderma types are EKV and progressive symmetric erythrokeratoderma (PSEK), which display phenotypic and genetic heterogeneity.
EKV, also called Mendes da Costa syndrome or erythrokeratodermia variabilis, normally presents at birth or early in infancy. In addition to fixed red/brown hyperkeratotic lesions which are frequently present on the trunk, limbs and buttocks, patients display migratory erythematous patches which can change in shape and location over time (Fig. 3) . PPK may also be present [95] . Symptoms may become aggravated by stress and changes in temperature [96] , indicating that environmental factors may also influence the skin phenotype. PSEK, also called Gottron syndrome or erythrokeratodermia progressive symmetrica, has clinical overlap with EKV, differing by the absence of transient erythema. The clinical similarities between EKV and PSEK may make it difficult to distinguish them [97] and it has been suggested that the two are the same disorder with different presentations [98] . Hearing, nails and development are normal in both conditions.
Mutations in GJB3 (Cx31) and GJB4 (Cx30.3) are associated with dominant and recessive EKV (Table 4) . EKV has also been described as a component of MEDNIK (Mental retardation, Enteropathy, Deafness, Neuropathy, Ichthyosis and Keratodermia) syndrome found in three families with a common ancestor and linked to a mutation in the AP1S1 gene, which encodes the σ1A subunit of the AP-1 complex [99] . This indicates that AP1S1 could be involved in the trafficking of Cx30.3/Cx31. The Cx30.3 mutation p.G12D is associated with EKV [100] and PSEK [101] , and the Cx30.3 mutation p.F137L has been implicated in EKV with [102] or without [103] erythema gyratum repens. A one base pair dominant insertion mutation in LOR was associated with a PSEK-like phenotype with pseudoainhum in one family [104] . However, the features appear to be consistent with loricrin keratoderma rather than true PSEK [98, 105] . Genetic heterogeneity for EKV and PSEK is indicated as not all EKV patients have mutations in either gene [106] [107] [108] [109] [110] and no mutations were found in LOR, GJB3 or GJB4 in PSEK patients [111, 112] .
A mouse model of EKV expressing the Cx31 mutant p.F137L has been developed [113] . However, mice homozygous for the mutant died during embryonic development and only 5% of murine skin was affected, indicated by hyperproliferation, in mice heterozygous for the mutant [113] .
Overexpression of EKV Cx31 mutants in vitro has demonstrated that the mutants have a primarily cytoplasmic localisation/display reduced GJ plaque formation and are associated with a cell death phenotype in certain cell types, including keratinocytes [50, 96, 114, 115] . There are some discrepancies in results obtained between studies for the EKV Cx31 mutants p.G12R and p.G12D, possibly due to differences between cell culture conditions and constructs.
p.G12D and p.G12R were reported to cause increased cell death in HeLa cells and immortalised keratinocyte cell lines and display defective trafficking to the plasma membrane [50, 96, 114] . However, in two other studies involving the expression of p.G12D [116] or p.G12R [115] in HeLa cells, trafficking defects were not evident, although p.G12R reduced cell viability.
Unlike for other syndromic Cx mutants, high levels of extracellular Ca 2+ did not rescue the cell death phenotype of cells expressing EKV Cx31 mutants, indicating that 'leaky' hemichannels are not responsible for the cell death phenotype [50] . It is unknown if this cell death phenotype is recapitulated in patient skin. In EKV patient skin, the Cx31 mutant p.R42P had a perinuclear localisation [96] but no obvious structural abnormalities were present [117] . ER stress is linked to different disorders (reviewed in [118] ). Components of the unfolded protein response (UPR), which is initiated in response to ER stress, are expressed in the skin and specific UPR proteins were found to be downregulated in squamous cell carcinoma and psoriasis [119] . ER stress is detected by the ER membrane proteins ATF6, IRE1α/β and PERK, resulting in UPR activation which leads to attenuation of protein production and an upregulation of ER chaperones such as BiP/GRP78 (reviewed in [120] ). For example, ATF6 is cleaved upon activation, translocating to the nucleus and acting as a transcription factor to upregulate the expression of other UPR proteins [121] .
An upregulation of UPR components and proteasomal markers was associated with the in vitro overexpression of EKV Cx31 mutants, but not wild-type, which indicates that ER stress, rather than aberrant hemichannels, is the main mechanism of cell death for these mutants [50] (Fig. 4) . Expression of an EKV Cx31 mutant was also found to lead to ER stress and p63-dependent apoptosis in zebrafish embryos [122] . A deletion in the 5′ UTR of the proteasome maturation protein (POMP) gene was found to be associated with Keratosis linearis with ichthyosis congenita and sclerosing keratoderma syndrome (KLICK) syndrome [123] . An aberrant distribution of POMP and increased expression of the UPR protein C/EBP homologous protein (CHOP) was found in patient skin, indicating ER stress is involved in disease pathology. Future studies involving characterisation of the expression and localisation of UPR proteins in EKV patient skin, and of tissue from patients with other Cx gene mutations, will give insights into the effects that Cx mutants have on UPR pathways in vivo.
Oculodentodigital dysplasia (ODDD) and palmoplantar keratoderma (PPK)
Specific GJA1 (Cx43) mutations are associated with ODDD (OMIM 164200), which is characterised by facial abnormalities, including microphthalmia, small teeth and small nose, and syndactyly type III. Two missense mutations, p.L11P [124] and p.K134E [125] , and two heterozygous deletion mutations leading to Cx43 truncations in the C-terminus (CT), c.679_680delAT (fs230) [126] and c.780_781delTG (fs260) [127] , have been associated with dominant ODDD with the additional feature of PPK. However, the fs230 mutant is not always associated with a skin phenotype [128] . 3D rat organotypic cultures composed of rat epidermal keratinocytes expressing the fs260 mutant showed decreased Cx26, Cx43 and loricrin levels and a reduction in Cx43 phosphorylation, SC thickness and resistance to acetone-induced injury, indicating that this mutant impairs epidermal differentiation and thus contributes to the disease phenotype [129] . The authors suggested that expression of the mutant could have a detrimental effect on epidermal junctional complexes, causing reduced resistance to stress [129] . Cx43 has a long CT which is known to interact with multiple partner proteins [20] thus a truncation could inhibit or disrupt interactions which normally occur with wild-type protein.
Fibroblasts from patients with the Cx43 mutants p.D3N and p.V216L, which are associated with ODDD only, showed reduced proliferation and migration, and delayed wound healing was observed in a p.G60S ODDD mutant mouse [41] . These investigations indicate that Cx43 mutants associated with ODDD could also have subclinical effects on wound healing in vivo in ODDD patients [41] . 
Conclusion
The differential expression of Cxs within the epidermis and during wound healing, as well as the association of Cx mutations with skin disease, demonstrates a critical role for Cxs in keratinocyte differentiation and wound closure. In vitro functional studies with Cx mutants and transgenic mice models have given insights into Cx function and how Cx mutants may cause disease. However, the precise functions of each Cx type during keratinocyte differentiation and how Cx mutants cause disease in vivo remain to be deciphered. The use of 3D culture models, the establishment of patient cell lines and a detailed characterisation of the patient transcriptome, for example, by next generation sequencing, should provide insights into the roles of Cxs in normal epidermal function and disease-associated mechanisms.
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